Identification of serum protein biomarkers for utrophin based DMD therapy

Despite promising therapeutic avenues, there is currently no effective treatment for Duchenne muscular dystrophy (DMD), a lethal monogenic disorder caused by the loss of the large cytoskeletal protein, dystrophin. A highly promising approach to therapy, applicable to all DMD patients irrespective to...

Descripción completa

Detalles Bibliográficos
Autores principales: Guiraud, Simon, Edwards, Benjamin, Squire, Sarah E., Babbs, Arran, Shah, Nandini, Berg, Adam, Chen, Huijia, Davies, Kay E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333102/
https://www.ncbi.nlm.nih.gov/pubmed/28252048
http://dx.doi.org/10.1038/srep43697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333102/
https://www.ncbi.nlm.nih.gov/pubmed/28252048
http://dx.doi.org/10.1038/srep43697

Ejemplares similares